Navigation Links
Hepatitis C Therapeutics Market - Taiwan
Date:8/2/2010

NEW YORK, Aug. 2 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Hepatitis C Therapeutics Market - Taiwan

http://www.reportlinker.com/p0236386/Hepatitis-C-Therapeutics-Market---Taiwan.html

This research service aims to provide an update on the epidemiology of Hepatitis C, including the prevalence and incidence, Market Engineering measurements, and government initiatives. It also covers patient source, load, and forecasts, while also outlining the key treaters involved. Current diagnostic methods are presented, followed by treatment regimens, their cost, and upcoming product launches. Clinical trials highlighting research into new treatments are also provided, along with an analysis of the pipeline. Additionally, there is a competitive analysis which includes the market structure, major participants, and future trends. This service covers the Hepatitis C therapeutics market in Taiwan. 

1 EXECUTIVE SUMMARY

Overview

1. Executive Summary - Taiwan

2 HEPATITIS C THERAPEUTICS MARKET

Market Overview

1. Introduction

2. Context for the Study

3. Report Scope and Segmentation

4. Methodology

5. Restraints in Forecasts

3 TAIWAN HEPATITIS C THERAPEUTICS MARKET

Market Overview

1. Introduction

2. Measurements

3. Government Initiatives

Hepatitis C Patients

1. Patient Load

2. Key Treaters and Patient Flow

3. Patient Forecasts

Diagnosis and Treatment

1. Diagnostic Tests and Monitoring

2. Treatment Regimens

3. Cost of Treatment

4. Product Launches

5. Clinical Trials

Competitive Analysis

1. Competitive Structure

2. Future Trends

3. Challenges Faced by Physicians

4 APPENDIX

Taiwan

1. Appendix-1

List of Figures

Chapter 3

Hepatitis C Therapeutics Market: Prevalence of Hepatitis C (Taiwan), 2006-2016 Hepatitis C Therapeutics Market: Incidence of Hepatitis C (Taiwan), 2006-2016

Hepatitis C Therapeutics Market: Classification of Patients who have Previously Received Interferon-based Therapy (Taiwan), 2009

Hepatitis C Therapeutics Market: Patient Classification of Current HCV Patients Based on Genotype (Taiwan), 2009

Hepatitis C Therapeutics Market: Number of Diagnosed Hepatitis C Patients (Taiwan), 2006-2016

Hepatitis C Therapeutics Market: Market Drivers Ranked in Order of Impact for Treated Chronic Hepatitis C Patient (Taiwan), 2010-2016

Hepatitis C Therapeutics Market: Market Restraints Ranked in Order of Impact for Treated Chronic Hepatitis C Patient (Taiwan), 2010-2016

Hepatitis C Therapeutics Market: Treated and Under Observation Chronic Hepatitis C Patients Forecasts (Taiwan), 2006-2016

Hepatitis C Therapeutics Market: Treated Chronic Hepatitis C Patients Forecasts (Taiwan), 2006-2016

Hepatitis C Therapeutics Market: Circumstances that Prompt Physicians to Test Patients for HCV (Taiwan), 2009

Hepatitis C Therapeutics Market: Key Diagnostic Tests Prior to Hepatitis C Treatment Therapy (Taiwan), 2009

Hepatitis C Therapeutics Market: Diagnostic Tests and Key Clinical Indicators (Taiwan), 2009

Hepatitis C Therapeutics Market: Treatment Regimen for Genotype 1 Chronic HCV Patients (Taiwan), 2009

Hepatitis C Therapeutics Market: Treatment Regimen for Genotype 2 and 3 Chronic HCV Patients (Taiwan), 2009

Hepatitis C Therapeutics Market: Treatment Regimen for Naive Chronic HCV Patients (Taiwan), 2009

Hepatitis C Therapeutics Market: Advantages and Drawbacks of Prescribed Drugs (Taiwan), 2009

Hepatitis C Therapeutics Market: Cost of Therapy (Listed Price) per Patient for Various Drug Regimens for the Treatment of Hepatitis C (Taiwan), 2009 3-29

Hepatitis C Therapeutics Market Product Launches (Taiwan), 2011 and 2013

Hepatitis C Therapeutics Market: List of Clinical Trials Conducted by Phase, Patient Age, Stage, Drug and Sponsor (Taiwan), 2009

Hepatitis C Therapeutics Market: List of Interferons in Development (World), 2009

Hepatitis C Therapeutics Market: List of Small Molecule Antivirals in Development (World), 2009

Hepatitis C Therapeutics Market: List of Non-Interferons in Development (World), 2009

Hepatitis C Therapeutics Market: Competitive Structure (Taiwan), 2009

To order this report:

Drug and Medication Industry: Hepatitis C Therapeutics Market - Taiwan

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
2. Drug in New Hepatitis C Clinical Trial
3. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
4. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
5. Dynavaxs HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial
6. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
7. Pharmasset Commences Dosing in 28-Day Combination Study of R7128 with Pegasys(R) plus Copegus(R) for Hepatitis C
8. Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response
9. R7128 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection
10. Potent Hepatitis C Virus Inhibitors Show Efficacy and Potential for Once Daily Dosing in Preclinical Studies
11. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
(Date:5/25/2016)... FDA 510(k) clearance covers Confocal Miniprobes ... and surgical applications Mauna Kea Technologies ... multidisciplinary confocal laser endomicroscopy (CLE) platform, today announced ... the 12 th 510(k) clearance from United ... FDA clearance covers Confocal Miniprobes indicated for use ...
(Date:5/25/2016)... YORK , May 25, 2016  According to ... reached $381 billion in 2015.  Though these are ... plenty of opportunity for success for companies that ... in search of new growth prospects medical device ... on research and development (R&D) than do companies ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook ... Council (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the ... is their favorite way to cook a hot dog, far outpacing other cooking methods ...
(Date:5/26/2016)... Atlanta, Georgia (PRWEB) , ... May 26, 2016 ... ... a certificate in intellectual property (IP) to its specialty academic programs. , Answering ... joins the college’s existing certificate programs in health law, and environmental and land ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac ... significant negative impact on long-term patient survival, reports a team of UPMC researchers ... this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical information ...
(Date:5/26/2016)... , ... May 26, 2016 , ... ... Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on June 4, 2016, ... public. , Dr. Maisel, founder of Retina Group of New York , ...
(Date:5/26/2016)... Indianapolis, Indiana (PRWEB) , ... May 26, 2016 ... ... national provider of healthcare supply chain solutions, today announced the organization has earned ... management meets international standards and is compliant with all rules and policies associated ...
Breaking Medicine News(10 mins):